![]() |
Volumn 48, Issue 11, 2008, Pages 835-843
|
Treatment of Parkinson's disease at present and in the future
|
Author keywords
COMT inhibitor; Dopamine agonists; Gene delivery therapy; Sleep attack; Valvular heart disease
|
Indexed keywords
AMANTADINE;
ANTIPARKINSON AGENT;
AROMATIC LEVO AMINO ACID DECARBOXYLASE;
BENSERAZIDE;
BROMOCRIPTINE;
CABERGOLINE;
CARBIDOPA;
CEP 1347;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DOPAMINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENTACAPONE;
ERGOT DERIVATIVE;
LEVODOPA;
PARVOVIRUS VECTOR;
PERGOLIDE;
PRAMIPEXOLE;
ROPINIROLE;
SELEGILINE;
TALIPEXOLE;
THREO 3,4 DIHYDROXYPHENYLSERINE;
TRIHEXYPHENIDYL;
CATECHOL DERIVATIVE;
CATECHOL METHYLTRANSFERASE;
ENZYME INHIBITOR;
INDOLE DERIVATIVE;
NITRILE;
AMNESIA;
ANOREXIA;
ATHETOSIS;
CELL DEATH;
CELL PROTECTION;
CELL THERAPY;
CHOREA;
CONFERENCE PAPER;
CONFUSION;
CONSTIPATION;
CORPUS STRIATUM;
DELIRIUM;
DOPAMINE DYSREGULATION SYNDROME;
DOPAMINE METABOLISM;
DRUG INDUCED DISEASE;
DRUG MARKETING;
DYSKINESIA;
DYSURIA;
EDEMA;
ENVIRONMENTAL FACTOR;
FIBROBLAST;
GENE;
GENE TARGETING;
GENE THERAPY;
HALLUCINATION;
HEART PALPITATION;
HEART VALVE REGURGITATION;
HUMAN;
ILLUSION;
JAPAN;
NAUSEA;
ORTHOSTATIC HYPOTENSION;
PARKINSON DISEASE;
PLEURA EFFUSION;
PLURIPOTENT STEM CELL;
PROTEIN AGGREGATION;
PSYCHOSIS;
SLEEP DISORDER;
SUBTHALAMIC NUCLEUS;
SUDDEN ONSET SLEEP ATTACK;
TACHYCARDIA;
VALVULAR HEART DISEASE;
VOMITING;
XEROSTOMIA;
ADENO ASSOCIATED VIRUS;
BIOLOGICAL THERAPY;
CLINICAL TRIAL;
DRUG ANTAGONISM;
GENE TRANSFER;
GENE VECTOR;
GENETICS;
PRACTICE GUIDELINE;
REVIEW;
ANTIPARKINSON AGENTS;
AROMATIC-L-AMINO-ACID DECARBOXYLASES;
CATECHOL O-METHYLTRANSFERASE;
CATECHOLS;
CLINICAL TRIALS AS TOPIC;
DEPENDOVIRUS;
DOPAMINE AGONISTS;
ENZYME INHIBITORS;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENETIC VECTORS;
HUMANS;
INDOLES;
NITRILES;
PARKINSON DISEASE;
PLURIPOTENT STEM CELLS;
PRACTICE GUIDELINES AS TOPIC;
TISSUE THERAPY;
|
EID: 63849218208
PISSN: 0009918X
EISSN: None
Source Type: Journal
DOI: 10.5692/clinicalneurol.48.835 Document Type: Conference Paper |
Times cited : (3)
|
References (10)
|